COST

1,018.21

+1.96%↑

159.85

-0.83%↓

187.27

-0.83%↓

PEP

165.87

-0.81%↓

67.19

+0.28%↑

COST

1,018.21

+1.96%↑

159.85

-0.83%↓

187.27

-0.83%↓

PEP

165.87

-0.81%↓

67.19

+0.28%↑

COST

1,018.21

+1.96%↑

159.85

-0.83%↓

187.27

-0.83%↓

PEP

165.87

-0.81%↓

67.19

+0.28%↑

COST

1,018.21

+1.96%↑

159.85

-0.83%↓

187.27

-0.83%↓

PEP

165.87

-0.81%↓

67.19

+0.28%↑

COST

1,018.21

+1.96%↑

159.85

-0.83%↓

187.27

-0.83%↓

PEP

165.87

-0.81%↓

67.19

+0.28%↑

Strona główna・Stock List・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Closed

SectorConsumer defensive

7.04 1

Buy Sell

Overview

Share price change

24h

Current

Min

7.04

Max

7.18

Key metrics
By Trading Economics
Income	-7.9M -10M
Sales	-5.3M 31M
Profit margin	-32.116
Employees	406

Dividends
By Dow Jones
Next Earnings	20 lut 2026

Market Stats
By TradingEconomics
Market Cap	-201K 241M
Previous open	6.04
Previous close	7.04

Lifecore Biomedical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 lut 2026, 23:21 UTC

Acquisitions, Mergers, Takeovers

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 lut 2026, 23:45 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 lut 2026, 23:40 UTC

Market Talk

Gold Falls on Possible Position Adjustments -- Market Talk

15 lut 2026, 23:06 UTC

Earnings

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 lut 2026, 23:04 UTC

Earnings

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 lut 2026, 23:04 UTC

Earnings

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 lut 2026, 23:01 UTC

Earnings

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 lut 2026, 23:01 UTC

Earnings

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 lut 2026, 22:58 UTC

Earnings

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 lut 2026, 22:53 UTC

Acquisitions, Mergers, Takeovers

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 lut 2026, 22:53 UTC

Acquisitions, Mergers, Takeovers

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 lut 2026, 22:52 UTC

Acquisitions, Mergers, Takeovers

Qube Shareholders to Receive A$5.20/Share in Cash

15 lut 2026, 22:52 UTC

Acquisitions, Mergers, Takeovers

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 lut 2026, 21:35 UTC

Earnings

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 lut 2026, 19:19 UTC

Acquisitions, Mergers, Takeovers

An S&P Global International Insider Bought Up Stock -- Barrons.com

14 lut 2026, 22:02 UTC

Earnings

Looking for Dividends? Consider Europe. -- Barrons.com

14 lut 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

13 lut 2026, 21:57 UTC

Earnings

Stocks Rise on Softer Inflation Data, but AI Jitters Trigger Worst Week Since November -- WSJ

13 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

13 lut 2026, 21:20 UTC

Earnings

Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers -- Barrons.com

13 lut 2026, 21:05 UTC

Acquisitions, Mergers, Takeovers

Constellation Software: Lumine Group Completes Acquisition of Synchronoss Technologies >CSU.T SNCR

13 lut 2026, 20:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13 lut 2026, 20:45 UTC

Market Talk

Dollar Pares Down Early Losses -- Market Talk

13 lut 2026, 20:39 UTC

Market Talk

Potential for Mild Winter Ahead Sinks Natural Gas for Week -- Market Talk

13 lut 2026, 20:28 UTC

Market Talk

Oil Settles Week Lower -- Market Talk

13 lut 2026, 19:51 UTC

Earnings

These Stocks Are Today's Movers: Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More -- Barrons.com

13 lut 2026, 19:32 UTC

Market Talk

Gold and Silver Climb to Finish Week In Positive Territory -- Market Talk

13 lut 2026, 19:32 UTC

Market Talk

Gold and Silver Climb to Finish Week In Positive Territory -- Market Talk

13 lut 2026, 19:29 UTC

Earnings

Big Tech's Spending Spree Could Limit Buybacks and Dividends -- Barrons.com

13 lut 2026, 18:18 UTC

Acquisitions, Mergers, Takeovers

Exxon, Walmart and 9 Other Stocks That Are Soaring Because Cash Is King Again -- Barrons.com

Peer Comparison

Price change

Lifecore Biomedical Inc Forecast

Rating Consensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Lifecore Biomedical Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.